橙子视频app安卓下载,91橙子视频,橙子视频旧款,橙子视频在线官网

CBR-5884 is a potent and selective inhibitor of 3-phosphoglycerate dehydrogenase (PHGDH), IC₅₀=33 μM. The action of PHGDH is the first committed step of serine biosesynthesis and certain cancer cells overexpress PHGDH. CBR-5884 inhibits serine biosesynthesis in cells with no effect on two other dehydrogenases, lactate dehydrogenase, and MDH1 and without general cytotoxic effects up to 40 μM. CBR-5884 is selectively toxic to tumor cells with high serine synthesis activity. A novel tool for selective inhibition of serine biosesynthesis in cells which also provides further proof that PHGDH is a viable target for the development of novel anticancer agents. 

Additional Information

Additional Information